197 related articles for article (PubMed ID: 19804979)
1. Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity.
Solomon VR; Hu C; Lee H
Bioorg Med Chem; 2009 Nov; 17(21):7585-92. PubMed ID: 19804979
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach.
Solomon VR; Hu C; Lee H
Bioorg Med Chem; 2010 Feb; 18(4):1563-72. PubMed ID: 20106668
[TBL] [Abstract][Full Text] [Related]
3. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF
J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety.
Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of chloroquine analogs with anti-breast cancer property.
Solomon VR; Hu C; Lee H
Eur J Med Chem; 2010 Sep; 45(9):3916-23. PubMed ID: 20561720
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
7. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
[TBL] [Abstract][Full Text] [Related]
8. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
11. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
ter Haar E; Day BW
Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
[TBL] [Abstract][Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines).
Liu ZY; Wang YM; Li ZR; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5661-4. PubMed ID: 19713108
[TBL] [Abstract][Full Text] [Related]
14. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
16. A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines.
Arteaga CL; Forseth BJ; Clark GM; Von Hoff DD
Cancer Res; 1987 Dec; 47(23):6248-53. PubMed ID: 3119196
[TBL] [Abstract][Full Text] [Related]
17. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
[TBL] [Abstract][Full Text] [Related]
18. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of [1,2,3,5]tetrazino[5,4-a]indoles, a new class of azolo-tetrazinones.
Barraja P; Diana P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2005 Jan; 13(2):295-300. PubMed ID: 15598552
[TBL] [Abstract][Full Text] [Related]
20. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]